Long Acting Drug Delivery Technologies Services Market Size, Share & Trends Analysis Report By Technique (Long-Acting Injectables, Long-Acting Hydrogels, Long-Acting Implants, Long-Acting Microneedles, And Nanocrystal Suspensions), Dosage Form (Injectables, Implantable, Topical/Transdermal, Vaginal), Type Of Molecule Delivered, Material Used And End-User, Region And Segment Forecasts, 2023-2031
Segmentation of acting drug delivery technologies services market-
By Technique-
- Long-Acting Injectables
- Long-Acting Hydrogels
- Long-Acting Implants
- Long-Acting Microneedles
- Nanocrystal Suspensions
By Dosage Form-
- Injectables
- Implantable
- Topical/Transdermal
- Vaginal
- Other Dosage Forms
By Type of Molecule Delivered-
- Small Molecules
- Biologics
- Other Molecules
By Material Used-
- Polymer Based
- Non-Polymer Based
By End User-
- Biopharmaceutical and Life science Companies
- Research and Academics
By Region-
North America-
- The US
- Canada
- Mexico
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Long-Acting Drug Delivery Technologies and Services Market Snapshot
Chapter 4. Global Long-Acting Drug Delivery Technologies and Services Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Technique Estimates & Trend Analysis
5.1. by Technique & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Technique:
5.2.1. Long-Acting Injectables
5.2.2. Long-Acting Hydrogels
5.2.3. Long-Acting Implants
5.2.4. LongActing Microneedles
5.2.5. Nanocrystal Suspensions
Chapter 6. Market Segmentation 2: By Type of Molecule Delivered Estimates & Trend Analysis
6.1. By Type of Molecule Delivered & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Type of Molecule Delivered:
6.2.1. Small Molecules
6.2.2. Biologics
6.2.3. Other Molecules (Peptides)
Chapter 7. Market Segmentation 3: by Material-Used Estimates & Trend Analysis
7.1. by Material-Used & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Material-Used:
7.2.1. Polymer-based
7.2.2. Non-polymer based
Chapter 8. Market Segmentation 4: By Dosage Forms Estimates & Trend Analysis
8.1. By Dosage Forms & Market Share, 2019 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Dosage Forms:
8.2.1. Long-acting Injectables
8.2.2. Long-acting Implantable
8.2.3. Topical / Transdermal
8.2.4. Vaginal
8.2.5. Other Dosage Forms
Chapter 9. Market Segmentation 5: By Distribution Channels Estimates & Trend Analysis
9.1. By Distribution Channels & Market Share, 2019 & 2031
9.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Distribution Channels:
9.2.1. Hospitals and Retail Pharmacies
9.2.2. Research and Academics
9.2.3. Others
Chapter 10. Long-Acting Drug Delivery Technologies and Services Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by Technique, 2023-2031
10.1.2. North America Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts By Type of Molecule Delivered, 2023-2031
10.1.3. North America Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by Material-Used, 2023-2031
10.1.4. North America Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts By Dosage Forms, 2023-2031
10.1.5. North America Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts By Distribution Channels, 2023-2031
10.1.6. North America Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
10.2. Europe
10.2.1. Europe Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by Technique, 2023-2031
10.2.2. Europe Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts By Type of Molecule Delivered, 2023-2031
10.2.3. Europe Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by Material-Used, 2023-2031
10.2.4. Europe Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts By Dosage Forms, 2023-2031
10.2.5. Europe Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts By Distribution Channels, 2023-2031
10.2.6. Europe Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
10.3. Asia Pacific
10.3.1. Asia Pacific Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by Technique, 2023-2031
10.3.2. Asia Pacific Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts By Type of Molecule Delivered, 2023-2031
10.3.3. Asia-Pacific Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by Material-Used, 2023-2031
10.3.4. Asia-Pacific Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts By Dosage Forms, 2023-2031
10.3.5. Asia-Pacific Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts By Distribution Channels, 2023-2031
10.3.6. Asia Pacific Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
10.4. Latin America
10.4.1. Latin America Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by Technique, 2023-2031
10.4.2. Latin America Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts By Type of Molecule Delivered, 2023-2031
10.4.3. Latin America Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by Material-Used, 2023-2031
10.4.4. Latin America Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts By Dosage Forms, 2023-2031
10.4.5. Latin America Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts By Distribution Channels, 2023-2031
10.4.6. Latin America Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
10.5. Middle East & Africa
10.5.1. Middle East & Africa Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by Technique, 2023-2031
10.5.2. Middle East & Africa Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts By Type of Molecule Delivered, 2023-2031
10.5.3. Middle East & Africa Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by Material-Used, 2023-2031
10.5.4. Middle East & Africa Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts By Dosage Forms, 2023-2031
10.5.5. Middle East & Africa Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and By Distribution Channels, 2023-2031
10.5.6. Middle East & Africa Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Adare Pharma Solutions
11.2.2. Alkermes
11.2.3. AMW Gmb
11.2.4. Camurus AB
11.2.5. Corium, LLC.
11.2.6. Creative Biolabs
11.2.7. Delpor, Inc.
11.2.8. Durect Corporation
11.2.9. Hanmi Pharm Co Ltd.
11.2.10. Heron Therapeutics, Inc.
11.2.11. Integral BioSystems
11.2.12. NANEXA AB
11.2.13. Other Prominent Players
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Long Acting Drug Delivery Technologies Services Market Size is valued at USD 13.7 Bn in 2023 and is predicted to reach USD 30.2 Bn by the year 2031
Long Acting Drug Delivery Technologies Services Market is predicted to develop at a 10.6% CAGR during the forecast period for 2024-2031.
Creative Biolabs, For Doz Pharma, Innocore Pharmaceuticals, Integral BioSystems, LATITUDE Pharmaceuticals, Navin Saxena Research and Technology Centre